Free Webinar | The Future of Supply Chain Management Post-COVID

June 24, 2020 | 11:00-12:00 pm EDT

Expect a thought-provoking panel discussion with Top 25 Pharma sponsors, Biogen and GSK, and vendors, PCI Clinical Services and Suvoda, to discuss how new trends in the clinical supply chain will shape the way clinical operations will be run in the future. Panelists will examine how emergent trial designs and supply chain strategies can be successfully implemented to address current clinical supply chain challenges amidst COVID. Panelists will speak about what clinical operations trends will remain or arise as our society moves beyond the impact of COVID-19.

Questions that will be addressed:
  • What trends addressing current supply chain challenges will remain a part of the clinical landscape moving forward?
  • How will trial designs shift and how will supply chain strategies change as a result?
  • Direct-to-patient shipment – where does it work, how to navigate its associated challenges?
  • What are some ways that vendors can collaborate more effectively to ensure treatments will continue to quickly advance?

John Ristuccia, Senior Vice President, Global Client Services, Suvoda

  • Scott Dixon, Senior Vice President, Product Strategy, Suvoda
  • Tris Evans, Vice President, Global Quality, PCI Clinical Services
  • Simi Nischal, Head of Core Technologies, Clinical Supply Chain, GlaxoSmithKline
  • Imran Shakur, Senior Manager, Clinical Supply Capabilities, Biogen

Speaker Biographies

John Ristuccia
Senior Vice President, Global Client Services, Suvoda

As Senior Vice President, Global Client Services at Suvoda, John provides comprehensive oversight, strategic direction and guidance for global services delivery teams. Prior to Suvoda, John oversaw services and operational planning for global accounts at Optymyze, where he was a key member in driving overall corporate strategy and executing business development initiatives for cross-functional business units including services, product, finance, marketing, and sales. John has also consulted with Fortune 2000 companies to structure and negotiate proposals for solutions bringing strategic outcomes that drove sales effectiveness and improved sales operations.

Scott Dixon
Senior Vice President, Product Strategy, Suvoda

Scott has spent his entire career in the life sciences technology industry, holding senior leadership positions at companies including ERT, Oracle, Phase Forward, WebMD, and Parexel. As Senior Vice President of Product Strategy, Scott oversees Suvoda’s product roadmap and vision while leading the teams responsible for development, management, and marketing. Prior to this role, Scott acted as Vice President of Strategic Partnerships at Suvoda, developing strategic initiatives for sales and business development, as well as establishing and enhancing Suvoda’s business partnership relationships. Scott is a versatile leader with a proven track record in consistently delivering new product and market strategies for startups and Fortune 100 companies in the life sciences and healthcare software application industry.

Tris Evans
Vice President, Global Quality, PCI Clinical Services

Tris leads the Clinical Quality teams across PCI. In Tris’ 6 years with PCI, he has been successfully leading and building a well-recognized Global Clinical Quality team, ensuring harmonization of Clinical Quality standards globally. Tris has worked in the pharma industry within various Quality roles for 20 years with experience in commercial, investigational and unlicensed medicine manufacture, release and supply. Tris is an EU Qualified Person (QP), qualifying in 2011 and is named on PCI commercial and clinical licenses in the UK and Ireland, with experience in multiple product dosage forms.

Simi Nischal
Head of Core Technologies, Clinical Supply Chain, GlaxoSmithKline

Simi is the Head of Core Technologies at GlaxoSmithKline. She is responsible for leading digital transformation within GlaxoSmithKline’s supply chain organization and supports a global team delivering and supporting technologies used across clinical supply chain, including IRT & Analytics. She has over 18 years of experience in clinical trial research and systems. Prior to GlaxoSmithKline, Simi held leadership positions at Medidata and Syneos Health. She holds an MBA from Temple University and has a keen interest in optimizing/standardizing IRT processes across industry.

Imran Shakur
Senior Manager, Clinical Supply Capabilities, Biogen

Imran Shakur is the Senior Manager, Clinical Supply Capabilities at Biogen. He is a seasoned leader and consultant with extensive expertise in SDLC management. Imran oversees IRT and other systems within clinical drug supply at Biogen.